Cambridge's Semma Therapeutics Lands $114M for Novel Diabetes Quest Post author:Sam Post published:November 29, 2017 Post category:BioPharma The round was co-led by Eight Roads Ventures and Cowen Healthcare Investments. Source: BioSpace You Might Also Like ThromboGenics Struggles to Find Patients for Phase II Eye Disease Trial December 7, 2017 Biohaven Eyes $100 Million IPO to Bankroll Trials of Shelved AstraZeneca PLC, Bristol-Myers Squibb Drugs April 9, 2017 Bristol-Myers Squibb May Be on the Market, But Pfizer Probably Won't Bite February 15, 2017
Biohaven Eyes $100 Million IPO to Bankroll Trials of Shelved AstraZeneca PLC, Bristol-Myers Squibb Drugs April 9, 2017
